Spinal Muscular Atrophy Treatment Market is Attribute to Reach CAGR of 13% Revenues by 2031
Spinal Muscular Atrophy Treatment Market Overview The global Spinal Muscular Atrophy (SMA) Treatment Market is anticipated to expand at a CAGR of approximately 13% through 2031, driven by increasing awareness of rare genetic disorders, continuous advancements in gene therapy, and the growing availability of innovative treatment options. Rising diagnosis rates through newborn screening programs, expanding […]
Continue Reading